Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Atopic Dermatitis
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Gastroenterology
  - BACK
  - Gastroenterology
  - Crohn's Disease
  - Ulcerative Colitis
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Paroxysmal Nocturnal Hemoglobinuria
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - COVID-19 Prevention
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN
  - IgAN & C3G
  - Renal Transplant Maintenance
  - Search for:
- Neurology
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Wet AMD
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Asthma
  - COPD
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Psoriatic Arthritis
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Urology
  - BACK
  - Urology
  - Uncomplicated Urinary Tract Infections
  - Search for:
- Search for:
Conference Reporter
Expert Directory
About Expert Perspectives
Login/Register
Search for:

experspadmin

Outcome Drivers in Chronic Lung Disease: Comorbidities, Vascular Factors, and Parenchymal Factors

Outcome Drivers in Chronic Lung Disease: Comorbidities, Vascular Factors, and Parenchymal Factors

clinical topic updates
By Justin Oldham, MD, MS

Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases

Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases

clinical topic updates
By Justin Oldham, MD, MS

Treatment Options for Nonresectable or Metastatic Gastrointestinal Stromal Tumors

Treatment Options for Nonresectable or Metastatic Gastrointestinal Stromal Tumors

expert roundtables
By Arun Singh, MD; Jonathan C. Trent, MD, PhD; Michael C. Heinrich, MD

Treatment for Patients With Recurrent Gastrointestinal Stromal Tumors

Treatment for Patients With Recurrent Gastrointestinal Stromal Tumors

expert roundtables
By Arun Singh, MD; Jonathan C. Trent, MD, PhD; Michael C. Heinrich, MD

Approach to Progressive Gastrointestinal Stromal Tumors

Approach to Progressive Gastrointestinal Stromal Tumors

patient care perspectives
By Jonathan C. Trent, MD, PhD

Load More

2026 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

Forgot Password?